Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel C5a regulators in inflammatory disease.

Masashi Mizuno1, Duncan S Cole

  • 1Department of Medical Biochemistry and Immunology, Cardiff University, School of Medicine, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK. MizunoM1@cardiff.ac.uk

Expert Opinion on Investigational Drugs
|July 19, 2005
PubMed
Summary

Excessive complement system activation, particularly C5a, drives inflammatory diseases. Targeting C5a offers a promising therapeutic strategy for conditions like rheumatoid arthritis and dermatitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postpartum TMA requiring dialysis with discordant complement tests: a case report.

CEN case reports·2026
Same author

Multidisciplinary introduction of peritoneal dialysis enabling ICU liberation and home-based care in Ebstein's anomaly with refractory ascites and CKD: a case report.

CEN case reports·2026
Same author

Exposure-based cognitive behavioral therapy delivered by assertive community treatment teams for severe mental illness with symptoms of anxiety: a cluster randomized controlled trial.

Psychological medicine·2026
Same author

Facility-based educational systems and peritonitis incidence in peritoneal dialysis: findings from a nationwide survey in Japan.

Clinical and experimental nephrology·2026
Same author

The Antibiotic effect of Silver CAPD Catheter on Peritoneal Dialysis-related infections (ASCA-PD) study: a multicenter randomized open-label trial protocol.

Trials·2025
Same author

Kidney Volume as a Predictor and Modifier of Acute Kidney Injury with Renin-Angiotensin System Inhibitors.

Clinical journal of the American Society of Nephrology : CJASN·2025

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • The complement system, a key part of innate immunity, protects against pathogens but can cause host damage.
  • Excessive complement activation, specifically C5a production, is implicated in inflammatory diseases such as rheumatoid arthritis and dermatitis.
  • Current clinical practice lacks effective agents for therapeutic C5a regulation.

Purpose of the Study:

  • To review the role of C5a in inflammatory diseases.
  • To discuss animal models used for studying C5a.
  • To explore current and future strategies for regulating C5a.

Main Methods:

  • Literature review of C5a's role in inflammation.
  • Analysis of animal models for C5a research.
  • Evaluation of therapeutic strategies targeting C5a.

Related Experiment Videos

Main Results:

  • C5a contributes significantly to the initiation and progression of inflammatory diseases.
  • Various strategies are being developed to regulate C5a production and function.
  • Existing approaches to C5a regulation have limitations.

Conclusions:

  • Modulating C5a is a viable therapeutic target for inflammatory disorders.
  • Further research into C5a regulation is needed.
  • Future drug development holds promise for managing C5a-mediated diseases.